GCMG vs UCFI
GCMG: A global alternative asset management firm providing customized, multi-asset class investment solutions for institutional and private clients. UCFI: A China-based provider of grain-based, biotech-enhanced health foods currently facing significant regulatory challenges and a Nasdaq trading suspension.
Side-by-side fundamentals
| Metric | GCMG | UCFI | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $12.64 | $5.51 | |
| Market cap | $2.6B | $288M | |
| P/E as of 2026-10-30 | 24.31 | n/a | |
| Net margin FY2025, SEC XBRL | +8.1% | n/a | |
| Operating margin FY2025, SEC XBRL | +23.9% | n/a | |
| ROE FY2025, SEC XBRL | +168.1% | n/a | |
| ROA | +5.6% | +1.9% | GCMG higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 14.29 | 0.13 | UCFI lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +8.5% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +7.7% | n/a | |
| Dividend yield as of 2026-09-03 | 3.80% | n/a | |
| Dividend streak (yrs) SEC XBRL | 3 | 0 | GCMG higher |
| Beta as of 2026-09-03 | 0.71 | 0.06 | |
| 1-year return as of 2026-10-30 close | +9.4% | +0.0% | GCMG higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.